Table of Contents Author Guidelines Submit a Manuscript
Journal of Skin Cancer
Volume 2013, Article ID 929364, 6 pages
http://dx.doi.org/10.1155/2013/929364
Review Article

Merkel Cell Carcinoma: The Past, the Present, and the Future

1Medical University of Vienna, 1090 Vienna, Austria
2Medical University of Vienna, Department of Otolaryngology, Head and Neck Surgery, 1090 Vienna, Austria

Received 20 October 2012; Revised 7 March 2013; Accepted 25 March 2013

Academic Editor: Justin Lee

Copyright © 2013 Inamaria Erovic and Boban M. Erovic. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. F. Merkel, “Tastzellen und Tastkörperchen bei den Hausthieren und beim Menschen,” Archiv für Mikroskopische Anatomie, vol. 11, no. 1, pp. 636–652, 1875. View at Publisher · View at Google Scholar · View at Scopus
  2. Z. Halata, M. Grim, and K. I. Bauman, “Friedrich Sigmund Merkel and his “Merkel cell”, morphology, development, and physiology: review and new results,” Anatomical Record Part A, vol. 271, no. 1, pp. 225–239, 2003. View at Google Scholar · View at Scopus
  3. V. Szeder, M. Grim, Z. Halata, and M. Sieber-Blum, “Neural crest origin of mammalian Merkel cells,” Developmental Biology, vol. 253, no. 2, pp. 258–263, 2003. View at Publisher · View at Google Scholar · View at Scopus
  4. B. L. Munger, “The intraepidermal innervation of the snout skin of the opossum. A light and electron microscope study, with observations on the nature of Merkel's Tastzellen,” Journal of Cell Biology, vol. 26, no. 1, pp. 79–97, 1965. View at Google Scholar · View at Scopus
  5. A. Iggo and A. R. Muir, “The structure and function of a slowly adapting touch corpuscle in hairy skin,” Journal of Physiology, vol. 200, no. 3, pp. 763–796, 1969. View at Google Scholar · View at Scopus
  6. R. Moll, A. Löwe, J. Laufer, and W. W. Franke, “Cytokeratin 20 in human carcinomas: a new histodiagnostic marker detected by monoclonal antibodies,” American Journal of Pathology, vol. 140, no. 2, pp. 427–447, 1992. View at Google Scholar · View at Scopus
  7. C. Toker, “Trabecular carcinoma of the skin,” Archives of Dermatology, vol. 105, no. 1, pp. 107–110, 1972. View at Publisher · View at Google Scholar · View at Scopus
  8. C. K. Tang and C. Toker, “Trabecular carcinoma of the skin. An ultrastructural study,” Cancer, vol. 42, no. 5, pp. 2311–2321, 1978. View at Google Scholar · View at Scopus
  9. M. Brunner, D. Thurnher, J. Pammer et al., “Expression of VEGF-A/C, VEGF-R2, PDGF-α/β, c-kit, EGFR, Her-2/Neu, Mcl-1 and Bmi-1 in Merkel cell carcinoma,” Modern Pathology, vol. 21, no. 7, pp. 876–884, 2008. View at Publisher · View at Google Scholar · View at Scopus
  10. C. De Wolf-Peeters, K. Marien, J. Mebis, and V. Desmet, “A cutaneous APUDoma or Merkel cell tumor? A morphologically recognizable tumor with a biological and histological malignant aspect in contrast with its clinical behavior,” Cancer, vol. 46, no. 8, pp. 1810–1816, 1980. View at Google Scholar · View at Scopus
  11. J. Y. Paik, G. Hall, A. Clarkson et al., “Immunohistochemistry for Merkel cell polyomavirus is highly specific but not sensitive for the diagnosis of Merkel cell carcinoma in the Australian population,” Human Pathology, vol. 42, pp. 1385–1390, 2011. View at Google Scholar
  12. T. Jaeger, J. Ring, and C. Andres, “Histological, immunohistological, and clinical features of merkel cell carcinoma in correlation to merkel cell polyomavirus status,” Journal of Skin Cancer, vol. 2012, Article ID 983421, 5 pages, 2012. View at Publisher · View at Google Scholar
  13. A. L. Dancey, S. S. Rayatt, C. Soon, A. Ilchshyn, I. Brown, and S. Srivastava, “Merkel cell carcinoma: a report of 34 cases and literature review,” Journal of Plastic, Reconstructive and Aesthetic Surgery, vol. 59, no. 12, pp. 1294–1299, 2006. View at Publisher · View at Google Scholar · View at Scopus
  14. J. C. Becker, C. S. Kauczok, S. Ugurel, S. Eib, E. B. Bröcker, and R. Houben, “Merkel cell carcinoma: molecular pathogenesis, clinical features and therapy,” Journal of the German Society of Dermatology, vol. 6, no. 9, pp. 709–720, 2008. View at Publisher · View at Google Scholar · View at Scopus
  15. J. Becker, C. Mauch, R. D. Kortmann et al., “Short German guidelines: Merkel cell carcinoma,” Journal of the German Society of Dermatology, vol. 6, pp. S15–S16, 2008. View at Google Scholar · View at Scopus
  16. M. Bobos, P. Hytiroglou, I. Kostopoulos, G. Karkavelas, and C. S. Papadimitriou, “Immunohistochemical distinction between Merkel cell carcinoma and small cell carcinoma of the lung,” American Journal of Dermatopathology, vol. 28, no. 2, pp. 99–104, 2006. View at Publisher · View at Google Scholar · View at Scopus
  17. G. J. Kontochristopoulos, P. G. Stavropoulos, K. Krasagakis, S. Goerdt, and C. C. Zouboulis, “Differentiation between Merkel cell carcinoma and malignant melanoma: an immunohistochemical study,” Dermatology, vol. 201, no. 2, pp. 123–126, 2000. View at Google Scholar · View at Scopus
  18. T. I. Tarantola, L. A. Vallow, M. Y. Halyard et al., “Prognostic factors in Merkel cell carcinoma: analysis of 240 cases,” Journal of the American Academy of Dermatology, vol. 68, pp. 425–432, 2013. View at Google Scholar
  19. A. Touzé, E. Le Bidre, H. Laude et al., “High levels of antibodies against merkel cell polyomavirus identify a subset of patients with merkel cell carcinoma with better clinical outcome,” Journal of Clinical Oncology, vol. 29, no. 12, pp. 1612–1619, 2011. View at Publisher · View at Google Scholar · View at Scopus
  20. K. G. Paulson, J. G. Iyer, A. R. Tegeder et al., “Transcriptome-wide studies of merkel cell carcinoma and validation of intratumoral cd8+ lymphocyte invasion as an independent predictor of survival,” Journal of Clinical Oncology, vol. 29, no. 12, pp. 1539–1546, 2011. View at Publisher · View at Google Scholar · View at Scopus
  21. H. Sihto, T. Böhling, H. Kavola et al., “Tumor infiltrating immune cells and outcome of Merkel cell carcinoma: a population-based study,” Clinical Cancer Research, vol. 18, pp. 2872–2881, 2012. View at Google Scholar
  22. R. Gollard, R. Weber, M. P. Kostky et al., “Merkel cell carcinoma: review of 22 cases with surgical, pathologic, and therapeutic considerations,” Cancer, vol. 88, pp. 1842–1851, 2000. View at Google Scholar
  23. H. Feng, M. Shuda, Y. Chang, and P. S. Moore, “Clonal integration of a polyomavirus in human Merkel cell carcinoma,” Science, vol. 319, no. 5866, pp. 1096–1100, 2008. View at Publisher · View at Google Scholar · View at Scopus
  24. M. Agelli, L. X. Clegg, J. C. Becker, and D. E. Rollison, “The etiology and epidemiology of merkel cell carcinoma,” Current Problems in Cancer, vol. 34, pp. 14–37, 2010. View at Google Scholar
  25. B. M. Erovic, A. Al Habeeb, L. Harris, D. P. Goldstein, D. Ghazarian, and J. C. Irish, “Significant overexpression of the Merkel cell polyomavirus (MCPyV) large T antigen in Merkel cell carcinoma,” Head & Neck Surgery, vol. 35, no. 2, pp. 184–189, 2013. View at Google Scholar
  26. R. Arora, Y. Chang, and P. S. Moore, “MCV and Merkel cell carcinoma: a molecular success story,” Current Opinion in Virology, vol. 2, pp. 489–498, 2012. View at Google Scholar
  27. Q. Zeng, B. P. Gomez, R. P. Viscidi et al., “Development of a DNA vaccine targeting Merkel cell polyomavirus,” Vaccine, vol. 30, pp. 1322–1329, 2012. View at Google Scholar
  28. H. Goepfert, D. Remmler, E. Silva, and B. Wheeler, “Merkel cell carcinoma (endocrine carcinoma of the skin) of the head and neck,” Archives of Otolaryngology, vol. 110, no. 11, pp. 707–712, 1984. View at Google Scholar · View at Scopus
  29. M. Poulsen, D. Rischin, E. Walpole et al., “High-risk Merkel cell carcinoma of the skin treated with synchronous carboplatin/etoposide and radiation: a Trans-Tasman Radiation Oncology Group Study-TROG 96:07,” Journal of Clinical Oncology, vol. 21, no. 23, pp. 4371–4376, 2003. View at Publisher · View at Google Scholar · View at Scopus
  30. J. D. Boyer, J. A. Zitelli, D. G. Brodland, and G. D'Angelo, “Local control of primary Merkel cell carcinoma: review of 45 cases treated with Mohs micrographic surgery with and without adjuvant radiation,” Journal of the American Academy of Dermatology, vol. 47, no. 6, pp. 885–892, 2002. View at Publisher · View at Google Scholar · View at Scopus
  31. T. K. George, A. Di Sant'Agnese, and J. M. Bennett, “Chemotherapy for metastatic Merkel cell carcinoma,” Cancer, vol. 57, pp. 178–182, 1986. View at Google Scholar
  32. B. D. Lawenda, M. G. Arnold, V. A. Tokarz et al., “Analysis of radiation therapy for the control of Merkel cell carcinoma head and neck based on 36 cases and a literature review,” Ear, Nose and Throat Journal, vol. 87, no. 11, pp. 634–643, 2008. View at Google Scholar · View at Scopus
  33. L. Mortier, X. Mirabel, C. Fournier, F. Piette, and E. Lartigau, “Radiotherapy alone for primary Merkel cell carcinoma,” Archives of Dermatology, vol. 139, pp. 1587–1590, 2003. View at Google Scholar
  34. L. C. Fang, B. Lemos, J. Douglas, J. Iyer, and P. Nghiem, “Radiation monotherapy as regional treatment for lymph node-positive merkel cell carcinoma,” Cancer, vol. 116, no. 7, pp. 1783–1790, 2010. View at Publisher · View at Google Scholar · View at Scopus
  35. A. M. Chen, J. Li, L. A. Beckett et al., “Differential response rates to irradiation among patients with human papillomavirus positive and negative oropharyngeal cancer,” Laryngoscope, vol. 123, no. 1, pp. 152–157, 2013. View at Google Scholar
  36. J. H. Raaf, C. Urmacher, and W. K. Knapper, “Trabecular (Merkel cell) carcinoma of the skin. Treatment of primary, recurrent, and metastatic disease,” Cancer, vol. 57, no. 1, pp. 178–182, 1986. View at Google Scholar · View at Scopus
  37. J. Redmond III, J. Perry, P. Sowray, S. J. Vukelja, and N. Dawson, “Chemotherapy of disseminated merkel-cell carcinoma,” American Journal of Clinical Oncology, vol. 14, no. 4, pp. 305–307, 1991. View at Google Scholar · View at Scopus
  38. M. Azagury, B. Chevallier, D. Atlan, Y. Graic, J. P. Dayot, and E. Thomine, “VP-16, cisplatin, doxorubicin, and bleomycin in metastatic Merkel cell carcinoma,” American Journal of Clinical Oncology, vol. 16, no. 2, pp. 102–104, 1993. View at Google Scholar · View at Scopus
  39. E. Bajetta, L. Rimassa, C. Carnaghi et al., “5-Fluorouracil, dacarbazine, and epirubicin in the treatment of patients with neuroendocrine tumors,” Cancer, vol. 83, pp. 372–378, 1998. View at Google Scholar
  40. T. Y. Eng, M. Naguib, C. D. Fuller, W. E. Jones, and T. S. Herman, “Treatment of recurrent merkel cell carcinoma: an analysis of 46 cases,” American Journal of Clinical Oncology, vol. 27, no. 6, pp. 576–583, 2004. View at Publisher · View at Google Scholar · View at Scopus
  41. E. R. Kokoska, M. S. Kokoska, B. T. Collins, D. R. Stapleton, and T. P. Wade, “Early aggressive treatment for merkel cell carcinoma improves outcome,” American Journal of Surgery, vol. 174, no. 6, pp. 688–693, 1997. View at Publisher · View at Google Scholar · View at Scopus
  42. E. Voog, P. Biron, J. P. Martin, and J. Y. Blay, “Chemotherapy for patients with locally advanced or metastatic Merkel cell carcinoma,” Cancer, vol. 85, pp. 2589–2595, 1999. View at Google Scholar
  43. M. Schlaak, T. Podewski, W. Von Bartenwerffer et al., “Induction of durable responses by oral etoposide monochemotherapy in patients with metastatic Merkel cell carcinoma,” European Journal of Dermatology, vol. 22, pp. 187–191, 2012. View at Google Scholar
  44. P. J. Allen, W. B. Bowne, D. P. Jaques, M. F. Brennan, K. Busam, and D. G. Coit, “Merkel cell carcinoma: prognosis and treatment of patients from a single institution,” Journal of Clinical Oncology, vol. 23, no. 10, pp. 2300–2309, 2005. View at Publisher · View at Google Scholar · View at Scopus
  45. R. P. DeMatteo, R. G. Maki, S. Singer, M. Gonen, M. F. Brennan, and C. R. Antonescu, “Results of tyrosine kinase inhibitor therapy followed by surgical resection for metastatic gastrointestinal stromal tumor,” Annals of Surgery, vol. 245, no. 3, pp. 347–352, 2007. View at Publisher · View at Google Scholar · View at Scopus
  46. R. J. Motzer, B. I. Rini, R. M. Bukowski et al., “Sunitinib in patients with metastatic renal cell carcinoma,” Journal of the American Medical Association, vol. 295, no. 21, pp. 2516–2524, 2006. View at Publisher · View at Google Scholar · View at Scopus
  47. R. Arora, M. Shuda, A. Guastafierro et al., “Survivin is a therapeutic target in Merkel cell carcinoma,” Science Translational Medicine, vol. 4, Article ID 133ra56, 2012. View at Google Scholar
  48. O. Catalano, G. Catalano, and A. Nunziata, “The echographic and computed radiographic findings in 2 cases of Merkel-cell carcinoma,” Radiologia Medica, vol. 94, no. 5, pp. 529–530, 1997. View at Google Scholar
  49. P. Peloschek, C. Novotny, C. Mueller-Mang et al., “Diagnostic imaging in Merkel cell carcinoma: lessons to learn from 16 cases with correlation of sonography, CT, MRI and PET,” European Journal of Radiology, vol. 73, no. 2, pp. 317–323, 2010. View at Publisher · View at Google Scholar · View at Scopus
  50. D. J. Kwekkeboom, A. M. Hoff, S. W. J. Lamberts, H. Yoe Oei, and E. P. Krenning, “Somatostatin analogue scintigraphy: a simple and sensitive method for the in vivo visualization of Merkel cell tumors and their metastases,” Archives of Dermatology, vol. 128, no. 6, pp. 818–821, 1992. View at Publisher · View at Google Scholar · View at Scopus
  51. R. M. Cabanas, “An approach for the treatment of penile carcinoma,” Cancer, vol. 39, no. 2, pp. 456–466, 1977. View at Google Scholar · View at Scopus
  52. M. Loyo, J. Schussel, E. Colantuoni et al., “Detection of Merkel cell virus and correlation with histologic presence of Merkel cell carcinoma in sentinel lymph nodes,” British Journal of Cancer, vol. 106, pp. 1314–1319, 2012. View at Google Scholar
  53. J. H. Leonard, J. R. Ramsay, J. H. Kearsley, and G. W. Birrell, “Radiation sensitivity of Merkel cell carcinoma cell lines,” International Journal of Radiation Oncology Biology Physics, vol. 32, no. 5, pp. 1401–1407, 1995. View at Publisher · View at Google Scholar · View at Scopus
  54. P. Mojica, D. Smith, and J. D. I. Ellenhorn, “Adjuvant radiation therapy is associated with improved survival in merkel cell carcinoma of the skin,” Journal of Clinical Oncology, vol. 25, no. 9, pp. 1043–1047, 2007. View at Publisher · View at Google Scholar · View at Scopus
  55. M. J. Veness, L. Perera, J. McCourt et al., “Merkel cell carcinoma: improved outcome with adjuvant radiotherapy,” ANZ Journal of Surgery, vol. 75, no. 5, pp. 275–281, 2005. View at Publisher · View at Google Scholar · View at Scopus
  56. C. S. L. Koh and M. J. Veness, “Role of definitive radiotherapy in treating patients with inoperable Merkel cell carcinoma: the Westmead Hospital experience and a review of the literature,” Australasian Journal of Dermatology, vol. 50, no. 4, pp. 249–256, 2009. View at Publisher · View at Google Scholar · View at Scopus
  57. M. J. Veness, C. E. Palme, and G. J. Morgan, “Merkel cell carcinoma: a review of management,” Current Opinion in Otolaryngology and Head and Neck Surgery, vol. 16, no. 2, pp. 170–174, 2008. View at Publisher · View at Google Scholar · View at Scopus
  58. R. E. Warner, M. J. Quinn, G. Hruby, R. A. Scolyer, R. F. Uren, and J. F. Thompson, “Management of Merkel cell carcinoma: the roles of lymphoscintigraphy, sentinel lymph node biopsy and adjuvant radiotherapy,” Annals of Surgical Oncology, vol. 15, no. 9, pp. 2509–2518, 2008. View at Publisher · View at Google Scholar · View at Scopus